Fundz

Acurx Pharmaceuticals, Llc reported raising $7.84 Million in an initial SEC Form D filing, from an offering of $6 Million

PUBLIC · ACXPJan 17, 2020

Amount Raised

$7.84 Million

$7.84 Million sold, per SEC Form D (first sale Jan 17, 2020)

Round Type

Venture

Staten IslandBiotechnologyTherapeuticsPharmaceuticalBiopharma

Who to call at Acurx Pharmaceuticals, and when

A new round usually means Acurx Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Acurx Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Acurx Pharmaceuticals, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acurx Pharmaceuticals

Location

Staten Island, New York, United States

About

Acurx Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. Their approach includes developing antibiotic candidates with a Gram-positive selective spectrum that blocks the active site of specific bacterial enzymes, inhibiting DNA replication. The company's R&D pipeline targets various Gram-positive bacteria such as MRSA and drug-resistant Streptococcus pneumoniae. Acurx is committed to addressing significant unmet medical needs in the antibiotic space.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acurx Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsSooyeon Y., ControllerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Acurx Pharmaceuticals's next move

See what Strategic adds

Acurx Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.